Each year, nearly 50,000 people in India die from snakebite — a toll that has persisted for generations, held in place partly by the limitations of antivenom technology unchanged since the nineteenth century. In 2026, researchers from India's Institute of Science and the Technical University of Denmark announced a recombinant nanobody-based antivenom capable of neutralizing toxins from multiple cobra species, produced not through animal immunization but through microbial systems in controlled laboratories. The work represents the first genuinely new direction in antivenom science in over a cen
Researchers develop recombinant nanobody antivenom effective against Indian cobras
Snakebite causes approximately 50,000 deaths annually in India alone, representing hundreds of thousands of deaths and disabilities worldwide from this neglected tropical disease.